XML 20 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 138,337,000 $ 79,470,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Amortization of deferred revenue and recognition of unbilled receivables (165,723,000) (112,508,000)
Depreciation 14,471,000 11,147,000
Amortization of intangibles 16,490,000 16,474,000
Change in excess inventory reserve 2,058,000 808,000
Amortization of premium and discount on investments, net (229,000) (4,293,000)
Stock-based compensation to employees 22,846,000 19,807,000
Stock-based compensation to Board of Directors and Scientific Advisory Board 1,052,000 1,133,000
Deferred income tax expense (benefit) 4,226,000 (2,242,000)
Retirement plan expense 6,676,000 4,242,000
Decrease (increase) in assets:    
Accounts receivable (13,974,000) (38,898,000)
Inventory (31,952,000) (20,953,000)
Other current assets (13,626,000) (2,854,000)
Other assets (33,540,000) (8,721,000)
Increase (decrease) in liabilities:    
Accounts payable and accrued expenses (3,311,000) (19,633,000)
Other current liabilities 1,429,000 (806,000)
Deferred revenue 160,021,000 144,200,000
Other liabilities 31,933,000 9,454,000
Net cash provided by operating activities 134,326,000 75,827,000
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchases of property and equipment (29,496,000) (19,213,000)
Purchases of intangibles (394,000) (25,000)
Purchases of investments (272,340,000) (604,153,000)
Proceeds from sale and maturity of investments 115,240,000 613,310,000
Net cash used in investing activities (186,990,000) (10,081,000)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from issuance of common stock 1,136,000 869,000
Payment of withholding taxes related to stock-based compensation to employees (14,880,000) (14,293,000)
Cash dividends paid (28,447,000) (21,329,000)
Net cash used in financing activities (42,191,000) (34,753,000)
(DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (94,855,000) 30,993,000
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD 630,012,000 131,627,000
CASH AND CASH EQUIVALENTS, END OF PERIOD $ 535,157,000 $ 162,620,000